List view / Grid view
The Critical Path for Rare Neurodegenerative Diseases (CP-RND) partnership was…
The Critical Path for Rare Neurodegenerative Diseases (CP-RND) partnership was launched to develop breakthrough treatments for neurodegenerative diseases like amyotrophic lateral sclerosis (ALS).
In a recent clinical study, ibudilast slowed brain shrinkage better…
In a recent clinical study, ibudilast slowed brain shrinkage better than a placebo in the brains of patients with multiple sclerosis...
The NIH is teaming with the government, biopharmaceutical, life science…
The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD...
